20th February 2024 (9 Topics)
1
Feb
2
Feb
3
Feb
5
Feb
6
Feb
7
Feb
8
Feb
9
Feb
10
Feb
12
Feb
13
Feb
14
Feb
15
Feb
16
Feb
17
Feb
19
Feb
20
Feb
21
Feb
22
Feb
23
Feb
24
Feb
26
Feb
27
Feb
28
Feb
29
Feb
In Karnataka, KFD peaks; vaccine efforts stalled
Context
Private manufacturers show reluctance in developing a vaccine for Kyasanur Forest Disease (KFD) due to its limited prevalence and lack of commercial viability despite significant research and development investments required.
Private Sector Hesitancy
- Lack of Interest from Manufacturers: Private manufacturers are showing reluctance to develop a vaccine for KFD due to limited market viability. The small number of cases and the substantial investment required for research and development make it unattractive for private companies to pursue.
- Urgent Need for Vaccination: Despite the disease's relatively low prevalence, recent fatalities and infections underscore the critical need for vaccination efforts to address KFD effectively. The reluctance of private manufacturers highlights the challenges of relying solely on private sector initiatives for addressing public health issues.
- Government Intervention Required: Collaborative efforts between the government, research institutions, and private sector stakeholders may be necessary to overcome the challenges posed by diseases with limited commercial appeal.
Historical Spread and Regional Impact
- Origins and Expansion: KFD, also known as "monkey fever," was first observed in 1956 in Karnataka's Kyasanur forest areas and has since spread to neighboring districts and states.
- Interstate Transmission: The transmission of KFD across state borders underscores the need for coordinated efforts and interstate cooperation to combat the disease effectively.
- Challenges of Regional Disease Management: Managing diseases like KFD requires coordinated efforts not only within states but also across regional boundaries.
Vaccination Efforts and Current Challenges
- Past Vaccination Success and Recent Setbacks: Previous vaccination efforts utilizing a chick embryo fibroblast culture-based vaccine were successful until recent years.
- Need for Alternative Measures: In light of the vaccine's ineffectiveness, there is an urgent need to explore alternative control measures and strategies for managing KFD outbreaks.
- Government Response and Future Outlook: While the availability of an effective vaccine remains uncertain in the near term, ongoing research and collaboration efforts offer hope for improved disease management strategies in the future.
You must be logged in to get greater insights. click here to login
More Articles
Courses
Study
Notes
Home
Resources
More
